Fund shareholders of Neurocrine Biosciences Inc
ISIN US64125C1099 · United States · LEI 549300FECER0XBN49756
- Fund shareholders
- 704
- Of which ETFs
- 199 505 other funds
- Value held
- ≈ 7.1B $ 6.9B $ · 1.4B SEK · 12M €
- Share of capital
- 41.8 % of 101.6M shares on Jul 22, 2026
704 funds hold this company. This table lists the 692 that declare it in a regulatory filing. The other 12 publish their holdings in their own reports. The “Fund reports” tab lists them, with their weight.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Dodge & Cox Stock Fund Dodge & Cox Funds | 3,964,000 | 668.1M $ | 0.56 % | 3.90 % | as of Jun 30, 2026 ↗ |
| iShares Core S&P Mid-Cap ETF iShares Trust | 3,441,037 | 579.9M $ | 0.47 % | 3.39 % | as of Jun 30, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3,193,267 | 538.2M $ | 0.02 % | 3.14 % | as of Jun 30, 2026 ↗ |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 2,304,996 | 388.5M $ | 0.21 % | 2.27 % | as of Jun 30, 2026 ↗ |
| JPMorgan Growth Advantage Fund J.P. Morgan Mutual Fund Investment Trust | 1,358,475 | 229M $ | 1.02 % | 1.34 % | as of Jun 30, 2026 ↗ |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1,329,829 | 224.1M $ | 0.48 % | 1.31 % | as of Jun 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,152,825 | 194.3M $ | 0.20 % | 1.13 % | as of Jun 30, 2026 ↗ |
| JPMorgan Mid Cap Growth Fund JPMorgan Trust II | 1,116,674 | 188.2M $ | 1.42 % | 1.10 % | as of Jun 30, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 700,051 | 118M $ | 1.30 % | 0.69 % | as of Jun 30, 2026 ↗ |
| VANGUARD EXPLORER FUND VANGUARD EXPLORER FUND | 637,614 | 106.4M $ | 0.48 % | 0.63 % | as of Jul 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 618,966 | 104.3M $ | 0.97 % | 0.61 % | as of Jun 30, 2026 ↗ |
| iShares S&P Mid-Cap 400 Growth ETF iShares Trust | 601,519 | 101.4M $ | 0.90 % | 0.59 % | as of Jun 30, 2026 ↗ |
| Invesco S&P MidCap Quality ETF Invesco Exchange-Traded Fund Trust | 599,829 | 100.1M $ | 1.84 % | 0.59 % | as of Jul 31, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 588,847 | 99.2M $ | 3.53 % | 0.58 % | as of Jun 30, 2026 ↗ |
| iShares MSCI USA Min Vol Factor ETF iShares Trust | 527,782 | 88M $ | 0.37 % | 0.52 % | as of Jul 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 517,971 | 82M $ | 0.19 % | 0.51 % | as of May 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF SPDR SERIES TRUST | 508,981 | 85.8M $ | 0.47 % | 0.50 % | as of Jun 30, 2026 ↗ |
| iShares Russell Mid-Cap Growth ETF iShares Trust | 503,286 | 84.8M $ | 0.39 % | 0.50 % | as of Jun 30, 2026 ↗ |
| VictoryShares Free Cash Flow ETF Victory Portfolios II | 477,009 | 80.4M $ | 1.04 % | 0.47 % | as of Jun 30, 2026 ↗ |
| VANGUARD CAPITAL OPPORTUNITY FUND VANGUARD HORIZON FUNDS | 416,300 | 70.2M $ | 0.21 % | 0.41 % | as of Jun 30, 2026 ↗ |
| iShares Russell Mid-Cap ETF iShares Trust | 406,536 | 68.5M $ | 0.12 % | 0.40 % | as of Jun 30, 2026 ↗ |
| Fidelity Mid Cap Index Fund Fidelity Salem Street Trust | 375,096 | 62.6M $ | 0.12 % | 0.37 % | as of Jul 31, 2026 ↗ |
| iShares Russell 1000 Growth ETF iShares Trust | 325,349 | 54.8M $ | 0.04 % | 0.32 % | as of Jun 30, 2026 ↗ |
| JNL/JPMorgan MidCap Growth Fund JNL Series Trust | 305,076 | 51.4M $ | 1.44 % | 0.30 % | as of Jun 30, 2026 ↗ |
| Dodge & Cox Balanced Fund Dodge & Cox Funds | 304,000 | 51.2M $ | 0.35 % | 0.30 % | as of Jun 30, 2026 ↗ |
| JPMorgan Active Growth ETF J.P. Morgan Exchange-Traded Fund Trust | 303,226 | 51.1M $ | 0.51 % | 0.30 % | as of Jun 30, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 299,296 | 47.4M $ | 0.25 % | 0.29 % | as of May 31, 2026 ↗ |
| Pacer US Cash Cows 100 ETF Pacer Funds Trust | 283,150 | 47.2M $ | 0.25 % | 0.28 % | as of Jul 31, 2026 ↗ |
| Schwab U.S. Mid-Cap ETF SCHWAB STRATEGIC TRUST | 271,303 | 42.9M $ | 0.29 % | 0.27 % | as of May 31, 2026 ↗ |
| VANGUARD STRATEGIC EQUITY FUND VANGUARD HORIZON FUNDS | 257,625 | 43.4M $ | 0.36 % | 0.25 % | as of Jun 30, 2026 ↗ |
| Swedbank Robur Aktiefond Pension Swedbank Robur Fonder AB | 241,300 | 302.8M SEK | 0.28 % | 0.24 % | as of Mar 31, 2026 ↗ |
| Carillon Eagle Mid Cap Growth Fund Carillon Series Trust | 231,944 | 39.1M $ | 0.75 % | 0.23 % | as of Jun 30, 2026 ↗ |
| THRIVENT MID CAP STOCK FUND Thrivent Mutual Funds | 229,482 | 38.3M $ | 1.23 % | 0.23 % | as of Jul 31, 2026 ↗ |
| Schwab U.S. Large-Cap Growth ETF SCHWAB STRATEGIC TRUST | 212,211 | 33.6M $ | 0.06 % | 0.21 % | as of May 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 189,239 | 30M $ | 0.02 % | 0.19 % | as of May 31, 2026 ↗ |
| First Trust Growth Strength ETF First Trust Exchange-Traded Fund | 186,257 | 31.4M $ | 2.51 % | 0.18 % | as of Jun 30, 2026 ↗ |
| Bridge Builder Large Cap Value Fund Bridge Builder Trust | 183,400 | 30.9M $ | 0.11 % | 0.18 % | as of Jun 30, 2026 ↗ |
| AP7 Aktiefond Sjunde AP-fonden | 177,263 | 222.5M SEK | 0.02 % | 0.17 % | as of Mar 31, 2026 ↗ |
| AB DISCOVERY GROWTH FUND, INC. AB DISCOVERY GROWTH FUND, INC. | 174,114 | 29.3M $ | 1.01 % | 0.17 % | as of Jun 30, 2026 ↗ |
| Hood River Small-Cap Growth Fund Manager Directed Portfolios | 173,881 | 29.3M $ | 0.44 % | 0.17 % | as of Jun 30, 2026 ↗ |
| VANGUARD S&P MID-CAP 400 INDEX FUND VANGUARD ADMIRAL FUNDS | 160,143 | 25.4M $ | 0.45 % | 0.16 % | as of May 31, 2026 ↗ |
| Impax Small Cap Fund IMPAX FUNDS SERIES TRUST I | 160,000 | 27M $ | 2.84 % | 0.16 % | as of Jun 30, 2026 ↗ |
| JPMorgan Mid Cap Equity Fund JPMorgan Trust I | 159,272 | 26.8M $ | 0.43 % | 0.16 % | as of Jun 30, 2026 ↗ |
| Swedbank Robur Transfer 70 Swedbank Robur Fonder AB | 156,500 | 196.4M SEK | 0.20 % | 0.15 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S & P 400(TM) Mid Cap Growth ETF SPDR SERIES TRUST | 155,483 | 26.2M $ | 0.90 % | 0.15 % | as of Jun 30, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 153,141 | 24.2M $ | 0.02 % | 0.15 % | as of May 31, 2026 ↗ |
| Dodge & Cox Global Stock Fund Dodge & Cox Funds | 151,163 | 25.5M $ | 0.20 % | 0.15 % | as of Jun 30, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 141,631 | 23.6M $ | 0.05 % | 0.14 % | as of Jul 31, 2026 ↗ |
| Carillon Scout Mid Cap Fund Carillon Series Trust | 138,465 | 23.3M $ | 0.55 % | 0.14 % | as of Jun 30, 2026 ↗ |
| VANGUARD RUSSELL 1000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 136,833 | 21.7M $ | 0.04 % | 0.13 % | as of May 31, 2026 ↗ |
| iShares U.S. Equity Factor Rotation Active ETF BlackRock ETF Trust | 136,591 | 22.8M $ | 0.06 % | 0.13 % | as of Jul 31, 2026 ↗ |
| Fidelity Enhanced Mid Cap Core ETF Fidelity Covington Trust | 136,513 | 23M $ | 0.31 % | 0.13 % | as of Jun 30, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund Janus Investment Fund | 134,953 | 22.7M $ | 0.39 % | 0.13 % | as of Jun 30, 2026 ↗ |
| JPMorgan Equity Focus ETF J.P. Morgan Exchange-Traded Fund Trust | 134,698 | 22.7M $ | 1.15 % | 0.13 % | as of Jun 30, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 134,180 | 21.2M $ | 0.02 % | 0.13 % | as of May 31, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 130,122 | 21.9M $ | 0.02 % | 0.13 % | as of Jun 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 125,643 | 21M $ | 1.82 % | 0.12 % | as of Jul 31, 2026 ↗ |
| Columbia Acorn Fund COLUMBIA ACORN TRUST | 116,190 | 19.6M $ | 0.71 % | 0.11 % | as of Jun 30, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 113,005 | 17.9M $ | 0.30 % | 0.11 % | as of May 29, 2026 ↗ |
| Fidelity Large Cap Growth Index Fund Fidelity Salem Street Trust | 112,172 | 18.7M $ | 0.04 % | 0.11 % | as of Jul 31, 2026 ↗ |
| Handelsbanken Hälsovård Tema Handelsbanken Fonder AB | 111,500 | 139.9M SEK | 0.63 % | 0.11 % | as of Mar 31, 2026 ↗ |
| AQR Long-Short Equity Fund AQR Funds | 108,538 | 18.3M $ | 0.23 % | 0.11 % | as of Jun 30, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 106,904 | 18M $ | 0.01 % | 0.11 % | as of Jun 30, 2026 ↗ |
| Schwab U.S. Large-Cap ETF SCHWAB STRATEGIC TRUST | 106,485 | 16.9M $ | 0.02 % | 0.10 % | as of May 31, 2026 ↗ |
| First Trust Health Care AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 105,135 | 17.5M $ | 1.67 % | 0.10 % | as of Jul 31, 2026 ↗ |
| Pacer US Large Cap Cash Cows Growth Leaders ETF Pacer Funds Trust | 103,520 | 17.3M $ | 0.78 % | 0.10 % | as of Jul 31, 2026 ↗ |
| JNL Mid Cap Index Fund JNL Series Trust | 101,950 | 17.2M $ | 0.46 % | 0.10 % | as of Jun 30, 2026 ↗ |
| Distillate U.S. Fundamental Stability & Value ETF ETF Series Solutions | 101,238 | 17.1M $ | 0.80 % | 0.10 % | as of Jun 30, 2026 ↗ |
| VANGUARD S&P MID-CAP 400 GROWTH INDEX FUND VANGUARD ADMIRAL FUNDS | 100,622 | 15.9M $ | 0.87 % | 0.10 % | as of May 31, 2026 ↗ |
| Allspring Diversified Capital Builder Fund ALLSPRING FUNDS TRUST | 100,000 | 16.9M $ | 0.65 % | 0.10 % | as of Jun 30, 2026 ↗ |
| JPMorgan Hedged Equity Fund JPMorgan Trust I | 97,084 | 16.4M $ | 0.09 % | 0.10 % | as of Jun 30, 2026 ↗ |
| Mid Cap Growth Stock Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 94,716 | 16M $ | 1.44 % | 0.09 % | as of Jun 30, 2026 ↗ |
| Fidelity Mid Cap Growth Index Fund Fidelity Salem Street Trust | 91,286 | 15.4M $ | 0.39 % | 0.09 % | as of Jun 30, 2026 ↗ |
| Schwab Fundamental U.S. Small Company ETF SCHWAB STRATEGIC TRUST | 89,904 | 14.2M $ | 0.16 % | 0.09 % | as of May 31, 2026 ↗ |
| iShares Core S&P U.S. Growth ETF iShares Trust | 87,362 | 14.7M $ | 0.05 % | 0.09 % | as of Jun 30, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 87,224 | 14.5M $ | 0.01 % | 0.09 % | as of Jul 31, 2026 ↗ |
| AQR Large Cap Defensive Style Fund AQR Funds | 82,762 | 13.9M $ | 1.28 % | 0.08 % | as of Jun 30, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 82,521 | 13.8M $ | 0.02 % | 0.08 % | as of Jul 31, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 81,984 | 13.7M $ | 0.04 % | 0.08 % | as of Jul 31, 2026 ↗ |
| EQ/Mid Cap Index Portfolio EQ Advisors Trust | 81,517 | 13.7M $ | 0.46 % | 0.08 % | as of Jun 30, 2026 ↗ |
| SMALL COMPANY GROWTH PORTFOLIO VANGUARD VARIABLE INSURANCE FUNDS | 78,090 | 13.2M $ | 0.78 % | 0.08 % | as of Jun 30, 2026 ↗ |
| FULLERTHALER BEHAVIORAL SMALL-MID CORE EQUITY Capitol Series Trust | 78,000 | 13.1M $ | 2.52 % | 0.08 % | as of Jun 30, 2026 ↗ |
| Swedbank Robur Healthcare Swedbank Robur Fonder AB | 77,300 | 97M SEK | 0.68 % | 0.08 % | as of Mar 31, 2026 ↗ |
| AMG GW&K Small/Mid Cap Core Fund AMG Funds | 76,376 | 12.9M $ | 1.56 % | 0.08 % | as of Jun 30, 2026 ↗ |
| John Hancock Multifactor Mid Cap ETF John Hancock Exchange-Traded Fund Trust | 74,531 | 12.6M $ | 0.22 % | 0.07 % | as of Jun 30, 2026 ↗ |
| Nuveen Quant Mid Cap Growth Fund TIAA-CREF Funds | 74,410 | 12.4M $ | 1.96 % | 0.07 % | as of Jul 31, 2026 ↗ |
| Nuveen Quant Small/Mid Cap Equity Fund TIAA-CREF Funds | 74,084 | 12.4M $ | 0.46 % | 0.07 % | as of Jul 31, 2026 ↗ |
| U.S. CORE EQUITY 1 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 73,835 | 12.3M $ | 0.03 % | 0.07 % | as of Jul 31, 2026 ↗ |
| Mid Cap Index Fund VALIC Co I | 73,601 | 11.7M $ | 0.45 % | 0.07 % | as of May 31, 2026 ↗ |
| Columbia Mid Cap Index Fund COLUMBIA FUNDS SERIES TRUST | 71,686 | 11.3M $ | 0.45 % | 0.07 % | as of May 31, 2026 ↗ |
| Swedbank Robur Transfer 80 Swedbank Robur Fonder AB | 71,500 | 89.7M SEK | 0.09 % | 0.07 % | as of Mar 31, 2026 ↗ |
| AQR Style Premia Alternative Fund AQR Funds | 70,946 | 12M $ | 0.47 % | 0.07 % | as of Jun 30, 2026 ↗ |
| Dimensional U.S. Marketwide Value ETF Dimensional ETF Trust | 70,759 | 11.8M $ | 0.08 % | 0.07 % | as of Jul 31, 2026 ↗ |
| Mercer US Small/Mid Cap Equity Fund Mercer Funds | 70,424 | 11.9M $ | 0.63 % | 0.07 % | as of Jun 30, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 70,000 | 11.8M $ | 1.57 % | 0.07 % | as of Jun 30, 2026 ↗ |
| Franklin U.S. Mid Cap Multifactor Index ETF Franklin Templeton ETF Trust | 69,960 | 11.8M $ | 0.77 % | 0.07 % | as of Jun 30, 2026 ↗ |
| MFS New Discovery Fund MFS SERIES TRUST I | 68,514 | 10.8M $ | 0.51 % | 0.07 % | as of May 31, 2026 ↗ |
| iShares Russell 1000 ETF iShares Trust | 67,619 | 11.4M $ | 0.02 % | 0.07 % | as of Jun 30, 2026 ↗ |
| Eaton Vance Worldwide Health Sciences Fund Eaton Vance Growth Trust | 67,430 | 10.7M $ | 1.41 % | 0.07 % | as of May 31, 2026 ↗ |
| Horizon Multi-Factor Small/Mid Cap Fund Horizon Funds | 67,229 | 10.6M $ | 1.42 % | 0.07 % | as of May 31, 2026 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| BNP Paribas Funds Health Care Innovators BNP Paribas Asset Management Luxembourg | 3.30 % | as of Dec 31, 2025 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 3.15 % | as of Sep 30, 2025 ↗ |
| Echiquier Health Impact for All La Financière de l'Échiquier | 1.75 % | as of Jun 30, 2025 ↗ |
| BNP Paribas Funds US Mid Cap BNP Paribas Asset Management Luxembourg | 1.50 % | as of Dec 31, 2025 ↗ |
| BNP Paribas Funds US Growth BNP Paribas Asset Management Luxembourg | 0.93 % | as of Dec 31, 2025 ↗ |
| BNP Paribas Funds Responsible US Value Multi-Factor Equity BNP Paribas Asset Management Luxembourg | 0.60 % | as of Dec 31, 2025 ↗ |
| BNP Paribas Funds Global Megatrends BNP Paribas Asset Management Luxembourg | 0.45 % | as of Dec 31, 2025 ↗ |
| BNP Paribas Funds Sustainable Global Multi-Factor Equity BNP Paribas Asset Management Luxembourg | 0.43 % | as of Dec 31, 2025 ↗ |
| Carmignac Investissement Carmignac Gestion | 0.16 % | as of Dec 31, 2025 ↗ |
| Carmignac Portfolio Investissement Carmignac Gestion Luxembourg S.A. | 0.16 % | as of Dec 31, 2025 ↗ |
| BNP Paribas Funds Multi-Asset Opportunities BNP Paribas Asset Management Luxembourg | 0.15 % | as of Dec 31, 2025 ↗ |
| Amundi Dynamique Climat Amundi Asset Management | 0.07 % | as of Sep 30, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 4.38 % | as of Jun 30, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 4.09 % | as of Jul 31, 2026 ↗ |
| Quantified Common Ground Fund Advisors Preferred Trust | 3.82 % | as of Jun 30, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 3.53 % | as of Jun 30, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 3.51 % | as of Jun 30, 2026 ↗ |
| BNP Paribas Funds Health Care Innovators BNP Paribas Asset Management Luxembourg | 3.30 % | as of Dec 31, 2025 ↗ |
| Baird Small/Mid Cap Growth Fund Baird Funds Inc | 3.26 % | as of Jun 30, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 3.16 % | as of Mar 31, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 3.15 % | as of Sep 30, 2025 ↗ |
| Impax Small Cap Fund IMPAX FUNDS SERIES TRUST I | 2.84 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 656 | +56 | 41,378,717 | +6.1 % |
| 2026Q2 | 600 | -3 | 39,005,444 | -0.7 % |
| 2026Q1 | 603 | -9 | 39,263,230 | -4.2 % |
| 2025Q4 | 612 | +11 | 40,996,168 | -4.4 % |
| 2025Q3 | 601 | -6 | 42,897,103 | +2.8 % |
| 2025Q2 | 607 | -27 | 41,721,880 | +7.3 % |
| 2025Q1 | 634 | -24 | 38,886,077 | +4.9 % |
| 2024Q4 | 658 | -8 | 37,086,789 | -2.5 % |
| 2024Q3 | 666 | +50 | 38,056,358 | +5.0 % |
| 2024Q2 | 616 | +15 | 36,239,577 | +1.1 % |
| 2024Q1 | 601 | +31 | 35,855,892 | +2.7 % |
| 2023Q4 | 570 | 34,930,179 |
Institutional managers
682 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 13,385,607 | 1.8B $ | as of Mar 31, 2026 |
| Dodge & Cox | 5,461,037 | 719.4M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 5,442,067 | 700.5M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 4,938,967 | 650.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,354,526 | 573.7M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 3,060,570 | 403.2M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 2,418,897 | 318.7M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,136,672 | 280.8M $ | as of Mar 31, 2026 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1,493,813 | 196.8M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 1,389,539 | 183.1M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 1,250,000 | 164.7M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,247,447 | 164.3M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 1,242,830 | 163.7M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,221,036 | 160.9M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,219,196 | 160.6M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 1,062,072 | 139.9M $ | as of Mar 31, 2026 |
| FIRST TRUST ADVISORS LP | 959,217 | 126.4M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 902,788 | 118.9M $ | as of Mar 31, 2026 |
| IEQ CAPITAL, LLC | 765,982 | 100.9M $ | as of Mar 31, 2026 |
| VICTORY CAPITAL MANAGEMENT INC | 731,609 | 96.4M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 724,000 | 95.4M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 711,762 | 93.8M $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 702,492 | 92.5M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 652,121 | 85.9M $ | as of Mar 31, 2026 |
| Fiera Capital Corp | 651,255 | 85.8M $ | as of Mar 31, 2026 |
Declared shareholders of Neurocrine Biosciences Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| JPMORGAN CHASE & CO. | 6.30 % | 6,338,240 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Neurocrine Biosciences Inc". https://titelia.com/en/stocks/neurocrine-biosciences-inc-US64125C1099